Publications To Date


    Filter Publications

    PAGE 4 OF 8 | DISPLAYING 46 - 60 OF 118 RESULTS

    Bronchud M.H. et al., Placental immune editing switch (PIES): learning about immunomodulatory pathways from a unique case report., [Epub ahead of print]., Oncotarget, Nov 11, 2016

    Barrott J.J. et al., Modeling synovial sarcoma metastasis in the mouse: PI3”²-lipid signaling and inflammation, [Epub ahead of print]., JEM, Nov 09, 2016

    Dolled-Filhart M. et al., Development of a Prototype Immunohistochemistry Assay to Measure Programmed Death Ligand-1 Expression in Tumor Tissue., 140(11):1259-1266., Arch Pathol Lab Med, Nov 01, 2016

    Fucikova J. et al., Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients, [Epub ahead of print]., Blood, Oct 24, 2016

    Mace T.A. et al., IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer, [Epub ahead of print]., Gut, Oct 21, 2016

    Weiss S.A. et al., Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts, [Epub ahead of print]., Trans. Med., Oct 19, 2016

    Keane C. et al., The T-cell receptor repertoire influences the tumor microenvironment and is associated with survival in aggressive B-cell lymphoma., [Epub ahead of print]., Clin. Can. Res., Sep 20, 2016

    Lizotte P.H. et al., Multiparametric profiling of non–small-cell lung cancers reveals distinct immunophenotypes, [Epub ahead of print]., JCI, Sep 08, 2016

    Kebriaei P. et al., Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells, [Epub ahead of print]., JCI, Sep 01, 2016

    Wallin J.J. et al., Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma, [Epub ahead of print]., Nat. Commun., Aug 30, 2016

    Thokala R. et al., Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123 Tumors, [Epub ahead of print]., PLoS ONE, Aug 22, 2016

    Danaher P. et al., Gene expression markers of Tumor Infiltrating Leukocytes, [Epub ahead of print]., BioRxiv, Aug 11, 2016

    Schats K.A. et al., Validated PD-L1 immunohistochemistry assays (E1L3N & SP142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system., [Epub ahead of print]., Histopathology, Aug 06, 2016

    Song I.H. et al., Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer., [Epub ahead of print]., Can. Res. Treat., Jul 27, 2016

    Weiss S.A. et al., Immunologic heterogeneity of tumor infiltrating lymphocyte composition in primary melanoma., [Epub ahead of print]., Human Pathology, Jul 26, 2016